FTM
First Turn Management Portfolio holdings
AUM
$536M
This Quarter Return
+14.87%
1 Year Return
+36.36%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$536M
AUM Growth
+$536M
(+8.1%)
Cap. Flow
-$21.4M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
46.73%
Holding
42
New
7
Increased
14
Reduced
14
Closed
7
Top Buys
| 1 |
Disc Medicine
IRON
|
$15.9M |
| 2 |
Arcellx
ACLX
|
$14.2M |
| 3 |
ADMA Biologics
ADMA
|
$9.57M |
| 4 |
NewAmsterdam Pharma
NAMS
|
$9.44M |
| 5 |
Akero Therapeutics
AKRO
|
$6.11M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$13.4M |
| 2 |
Glaukos
GKOS
|
$13.4M |
| 3 |
Exact Sciences
EXAS
|
$13M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$11.9M |
| 5 |
Vaxcyte
PCVX
|
$10.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
NewAmsterdam Pharma
NAMS
$2.71B
| $9.44M | 1.76% |
+521,097
| New | +$9.44M |
|
27
HealthEquity
HQY
$7.68B
| $8.47M | 1.58% |
80,880
-3,086
| -4% | -$323K |
|
28
ARS Pharmaceuticals
SPRY
$1.1B
| $7.96M | 1.48% |
455,953
-213,057
| -32% | -$3.72M |
|
29
Vera Therapeutics
VERA
$1.44B
| $7.3M | 1.36% |
309,666
-313,946
| -50% | -$7.4M |
|
30
Soleno Therapeutics
SLNO
$3.57B
| $7.23M | 1.35% |
86,332
+57,217
| +197% | +$4.79M |
|
31
Harrow
HROW
$1.4B
| $6.99M | 1.3% |
228,761
+39,932
| +21% | +$1.22M |
|
|
32
Akero Therapeutics
AKRO
$3.74B
| $6.11M | 1.14% |
+114,554
| New | +$6.11M |
|
33
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.83M | 1.09% |
+17,879
| New | +$5.83M |
|
34
KalVista Pharmaceuticals
KALV
$678M
| $2.42M | 0.45% |
+214,138
| New | +$2.42M |
|
|
BBNX
35
Beta Bionics, Inc. Common Stock
BBNX
$819M
| $2.29M | 0.43% |
+157,194
| New | +$2.29M |
|
|
BPMC
36
DELISTED
Blueprint Medicines
BPMC
| – | – |
-92,033
| Closed | -$8.15M |
|
|
37
Exact Sciences
EXAS
$9.09B
| – | – |
-300,909
| Closed | -$13M |
|
|
38
Glaukos
GKOS
$5.5B
| – | – |
-136,241
| Closed | -$13.4M |
|
39
MoonLake Immunotherapeutics
MLTX
$3.54B
| – | – |
-179,196
| Closed | -$7M |
|
|
40
Vaxcyte
PCVX
$4.1B
| – | – |
-276,905
| Closed | -$10.5M |
|
41
Praxis Precision Medicines
PRAX
$958M
| – | – |
-71,775
| Closed | -$2.72M |
|
|
SWTX
42
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-304,076
| Closed | -$13.4M |
|